annual CFF:
$66.20M-$35.12M(-34.66%)Summary
- As of today (September 3, 2025), ARQT annual cash flow from financing activities is $66.20 million, with the most recent change of -$35.12 million (-34.66%) on December 31, 2024.
- During the last 3 years, ARQT annual CFF has fallen by -$215.75 million (-76.52%).
- ARQT annual CFF is now -78.06% below its all-time high of $301.80 million, reached on December 31, 2022.
Performance
ARQT Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$1.38M+$985.00K(+249.37%)Summary
- As of today (September 3, 2025), ARQT quarterly cash flow from financing activities is $1.38 million, with the most recent change of +$985.00 thousand (+249.37%) on June 30, 2025.
- Over the past year, ARQT quarterly CFF has dropped by -$75.00 thousand (-5.15%).
- ARQT quarterly CFF is now -99.52% below its all-time high of $284.99 million, reached on September 30, 2022.
Performance
ARQT quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$95.24M-$75.00K(-0.08%)Summary
- As of today (September 3, 2025), ARQT TTM cash flow from financing activities is -$95.24 million, with the most recent change of -$75.00 thousand (-0.08%) on June 30, 2025.
- Over the past year, ARQT TTM CFF has dropped by -$358.62 million (-136.16%).
- ARQT TTM CFF is now -125.49% below its all-time high of $373.72 million, reached on September 30, 2022.
Performance
ARQT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ARQT Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -34.7% | -5.2% | -136.2% |
| 3 y3 years | -76.5% | +22.0% | -207.3% |
| 5 y5 years | -28.9% | +346.6% | -136.1% |
ARQT Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -78.1% | at low | -99.5% | +101.4% | -125.5% | at low |
| 5 y | 5-year | -78.1% | at low | -99.5% | +101.4% | -125.5% | at low |
| alltime | all time | -78.1% | +829.9% | -99.5% | +101.4% | -125.5% | at low |
ARQT Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.38M(+249.4%) | -$95.24M(+0.1%) |
| Mar 2025 | - | $395.00K(-100.4%) | -$95.17M(-243.8%) |
| Dec 2024 | $66.20M(-34.7%) | -$97.41M(<-9900.0%) | $66.20M(-74.8%) |
| Sep 2024 | - | $394.00K(-72.9%) | $262.90M(-0.2%) |
| Jun 2024 | - | $1.46M(-99.1%) | $263.38M(+0.1%) |
| Mar 2024 | - | $161.76M(+62.9%) | $262.99M(+159.6%) |
| Dec 2023 | $101.32M(-66.4%) | $99.29M(>+9900.0%) | $101.32M(+3281.9%) |
| Sep 2023 | - | $867.00K(-18.7%) | $3.00M(-99.0%) |
| Jun 2023 | - | $1.07M(+967.0%) | $287.12M(-0.0%) |
| Mar 2023 | - | $100.00K(-89.6%) | $287.18M(-4.8%) |
| Dec 2022 | $301.80M(+7.0%) | $962.00K(-99.7%) | $301.80M(-19.2%) |
| Sep 2022 | - | $284.99M(>+9900.0%) | $373.72M(+320.9%) |
| Jun 2022 | - | $1.13M(-92.3%) | $88.79M(-0.1%) |
| Mar 2022 | - | $14.72M(-79.8%) | $88.85M(-68.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $281.95M(-5.4%) | $72.88M(>+9900.0%) | $281.95M(-16.6%) |
| Sep 2021 | - | $63.00K(-94.7%) | $337.98M(+0.0%) |
| Jun 2021 | - | $1.19M(-99.4%) | $337.95M(+0.3%) |
| Mar 2021 | - | $207.81M(+61.2%) | $337.07M(+13.1%) |
| Dec 2020 | $298.14M(+220.2%) | $128.91M(>+9900.0%) | $298.14M(+13.2%) |
| Sep 2020 | - | $34.00K(-89.0%) | $263.48M(-0.0%) |
| Jun 2020 | - | $309.00K(-99.8%) | $263.54M(+0.1%) |
| Mar 2020 | - | $168.89M(+79.2%) | $263.40M(+178.7%) |
| Dec 2019 | $93.10M(+51.2%) | $94.25M(>+9900.0%) | $94.50M(>+9900.0%) |
| Sep 2019 | - | $88.00K(-47.6%) | $256.00K(+52.4%) |
| Jun 2019 | - | $168.00K(>+9900.0%) | $168.00K(>+9900.0%) |
| Mar 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2018 | $61.59M(+765.2%) | $0.00 | $0.00 |
| Dec 2017 | $7.12M | - | - |
FAQ
- What is Arcutis Biotherapeutics, Inc. annual cash flow from financing activities?
- What is the all time high annual CFF for Arcutis Biotherapeutics, Inc.?
- What is Arcutis Biotherapeutics, Inc. annual CFF year-on-year change?
- What is Arcutis Biotherapeutics, Inc. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Arcutis Biotherapeutics, Inc.?
- What is Arcutis Biotherapeutics, Inc. quarterly CFF year-on-year change?
- What is Arcutis Biotherapeutics, Inc. TTM cash flow from financing activities?
- What is the all time high TTM CFF for Arcutis Biotherapeutics, Inc.?
- What is Arcutis Biotherapeutics, Inc. TTM CFF year-on-year change?
What is Arcutis Biotherapeutics, Inc. annual cash flow from financing activities?
The current annual CFF of ARQT is $66.20M
What is the all time high annual CFF for Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. all-time high annual cash flow from financing activities is $301.80M
What is Arcutis Biotherapeutics, Inc. annual CFF year-on-year change?
Over the past year, ARQT annual cash flow from financing activities has changed by -$35.12M (-34.66%)
What is Arcutis Biotherapeutics, Inc. quarterly cash flow from financing activities?
The current quarterly CFF of ARQT is $1.38M
What is the all time high quarterly CFF for Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. all-time high quarterly cash flow from financing activities is $284.99M
What is Arcutis Biotherapeutics, Inc. quarterly CFF year-on-year change?
Over the past year, ARQT quarterly cash flow from financing activities has changed by -$75.00K (-5.15%)
What is Arcutis Biotherapeutics, Inc. TTM cash flow from financing activities?
The current TTM CFF of ARQT is -$95.24M
What is the all time high TTM CFF for Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. all-time high TTM cash flow from financing activities is $373.72M
What is Arcutis Biotherapeutics, Inc. TTM CFF year-on-year change?
Over the past year, ARQT TTM cash flow from financing activities has changed by -$358.62M (-136.16%)